Fluorecare COMBO 9in1 test | SARS-CoV-2 | Influenza A+B | RSV | Adenovirus | hMPV | Rhinovirus | PIV | Mycoplasma Pneumoniae | 1 piece

• sample material: nasal swab, nasopharyngeal swab or throat swab
• painless sample collection
• high-quality product
• rapid results in just 12 minutes
• single packaging
• intended for professional use

Test specification

• SARS-CoV-2: specificity: 100%, sensitivity: 92.93%, accuracy: 96.11%
• Influenza A: specificity: 96.88%, sensitivity: 95.71%, accuracy: 96.27%
• Influenza B: specificity: 96.88%, sensitivity: 92.86%, accuracy: 94.78%
• RSV: specificity: 100%, sensitivity: 98.72%, accuracy: 99.44%
• Adenovirus: specificity: 100%, sensitivity: 98.06%, accuracy: 99.03%
• hMPV: specificity: 100%, sensitivity: 98.04%, accuracy: 99.05%
• Rhinovirus: specificity: 98.68%, sensitivity: 97.48%, accuracy: 98.06%
• PIV: specificity: 98.75%, sensitivity: 98.08%, accuracy: 98.42%
• Mycoplasma pneumoniae: specificity: 96.36%, sensitivity: 97.01%, accuracy: 96.72%

The package contains

• 1 test cassette
• 1 single-use sterile swab
• 1 extraction buffer
• user manual

Test application

• This test is designed for the qualitative assessment of infections caused by SARS-CoV-2, Influenza A, Influenza B, RSV, Adenovirus, Human Metapneumovirus (hMPV), Rhinovirus, Parainfluenza Virus (PIV), and Mycoplasma pneumoniae. It enables the rapid detection or exclusion of the cause of a patient’s symptoms.
• The test is particularly recommended for pediatricians, as children are exposed to such infections in school and preschool environments. Painless sample collection makes it suitable for the youngest patients.
• It is also intended for screening in primary care facilities and general practitioners’ offices, allowing for the rapid confirmation or exclusion of infection with one of the six most common respiratory pathogens.

Product Identification Data and Responsible Entities

EAN Code: 6971348762995